BioMed Realty Trust Inc., San Diego, has priced a public offering of 5.7 million shares of common stock at $25.50 per share. BioMed said it has granted the underwriters an option to buy up to 855,000 additional shares to cover any overallotments. The underwriters are: Raymond James & Associates, Morgan Stanley & Co., Wachovia Capital Markets LLC, KeyBanc Capital Markets Inc., Robert W. Baird & Co., Credit Suisse Securities (USA) LLC, RBC Capital Markets Corp., and Stifel, Nicolaus & Co.
Processing Content
